124 related articles for article (PubMed ID: 7526959)
1. The calcitonin gene-related peptide antagonist CGRP8-37 increases the latency to withdrawal responses in rats.
Yu LC; Hansson P; Lundeberg T
Brain Res; 1994 Aug; 653(1-2):223-30. PubMed ID: 7526959
[TBL] [Abstract][Full Text] [Related]
2. Opioid antagonists naloxone, beta-funaltrexamine and naltrindole, but not nor-binaltorphimine, reverse the increased hindpaw withdrawal latency in rats induced by intrathecal administration of the calcitonin gene-related peptide antagonist CGRP8-37.
Yu LC; Hansson P; Lundeberg T
Brain Res; 1995 Nov; 698(1-2):23-9. PubMed ID: 8581488
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal CGRP8-37-induced bilateral increase in hindpaw withdrawal latency in rats with unilateral inflammation.
Yu LC; Hansson P; Brodda-Jansen G; Theodorsson E; Lundeberg T
Br J Pharmacol; 1996 Jan; 117(1):43-50. PubMed ID: 8825341
[TBL] [Abstract][Full Text] [Related]
4. The calcitonin gene-related peptide antagonist CGRP8-37 increases the latency to withdrawal responses bilaterally in rats with unilateral experimental mononeuropathy, an effect reversed by naloxone.
Yu LC; Hansson P; Lundeberg T
Neuroscience; 1996 Mar; 71(2):523-31. PubMed ID: 9053804
[TBL] [Abstract][Full Text] [Related]
5. Unilateral injection of calcitonin gene-related peptide (CGRP) induces bilateral oedema formation and release of CGRP-like immunoreactivity in the rat hindpaw.
Bileviciute I; Stenfors C; Theodorsson E; Lundeberg T
Br J Pharmacol; 1998 Nov; 125(6):1304-12. PubMed ID: 9863661
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal CGRP(8-37) results in a bilateral increase in hindpaw withdrawal latency in rats with a unilateral thermal injury.
Löfgren O; Yu LC; Theodorsson E; Hansson P; Lundeberg T
Neuropeptides; 1997 Dec; 31(6):601-7. PubMed ID: 9574827
[TBL] [Abstract][Full Text] [Related]
7. Opioids modulate the calcitonin gene-related peptide8-37-mediated hindpaw withdrawal latency increase in thermally injured rats.
Löfgren O; Yu LC; Theodorsson E; Hansson P; Lundeberg T
Neuropeptides; 1998 Apr; 32(2):173-7. PubMed ID: 9639257
[TBL] [Abstract][Full Text] [Related]
8. Effects of calcitonin gene-related peptide-(8-37) on withdrawal responses in rats with inflammation.
Yu LC; Hansson P; Lundeberg S; Lundeberg T
Eur J Pharmacol; 1998 Apr; 347(2-3):275-82. PubMed ID: 9653894
[TBL] [Abstract][Full Text] [Related]
9. Anti-nociceptive effects of calcitonin gene-related peptide in nucleus raphe magnus of rats: an effect attenuated by naloxone.
Huang Y; Brodda-Jansen G; Lundeberg T; Yu LC
Brain Res; 2000 Aug; 873(1):54-9. PubMed ID: 10915810
[TBL] [Abstract][Full Text] [Related]
10. Involvement of CGRP and CGRPl receptor in nociception in the basolateral nucleus of amygdala of rats.
Li N; Liang J; Fang CY; Han HR; Ma MS; Zhang GX
Neurosci Lett; 2008 Oct; 443(3):184-7. PubMed ID: 18687383
[TBL] [Abstract][Full Text] [Related]
11. Involvement of CGRP and CGRP1 receptor in nociception in the nucleus accumbens of rats.
Li N; Lundeberg T; Yu LC
Brain Res; 2001 May; 901(1-2):161-6. PubMed ID: 11368963
[TBL] [Abstract][Full Text] [Related]
12. Involvement of calcitonin gene-related peptide and its receptor in anti-nociception in the periaqueductal grey of rats.
Yu LC; Weng XH; Wang JW; Lundeberg T
Neurosci Lett; 2003 Sep; 349(1):1-4. PubMed ID: 12946572
[TBL] [Abstract][Full Text] [Related]
13. A calcitonin gene-related peptide (CGRP) antagonist (CGRP8-37) inhibits microvascular responses induced by CGRP and capsaicin in skin.
Hughes SR; Brain SD
Br J Pharmacol; 1991 Nov; 104(3):738-42. PubMed ID: 1797334
[TBL] [Abstract][Full Text] [Related]
14. Effect of a calcitonin gene-related peptide antagonist (CGRP8-37) on skin vasodilatation and oedema induced by stimulation of the rat saphenous nerve.
Escott KJ; Brain SD
Br J Pharmacol; 1993 Oct; 110(2):772-6. PubMed ID: 8242250
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive effect of calcitonin gene-related peptide in the central nucleus of amygdala: activating opioid receptors through amygdala-periaqueductal gray pathway.
Xu W; Lundeberg T; Wang YT; Li Y; Yu LC
Neuroscience; 2003; 118(4):1015-22. PubMed ID: 12732246
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal administration of CGRP in the rat attenuates a facilitation of the tail flick reflex induced by either substance P or noxious cutaneous stimulation.
Cridland RA; Henry JL
Neurosci Lett; 1989 Jul; 102(2-3):241-6. PubMed ID: 2478930
[TBL] [Abstract][Full Text] [Related]
17. Antinociceptive effects of calcitonin gene-related peptide injected into periaqueductal grey of rats with mononeuropathy.
Xu S; Lundeberg T; Yu L
Brain Res; 2000 Mar; 859(2):358-60. PubMed ID: 10719085
[TBL] [Abstract][Full Text] [Related]
18. Involvement of substance P and calcitonin gene-related peptide in development and maintenance of neuropathic pain from spinal nerve injury model of rat.
Lee SE; Kim JH
Neurosci Res; 2007 Jul; 58(3):245-9. PubMed ID: 17428562
[TBL] [Abstract][Full Text] [Related]
19. Calcitonin gene-related peptide enhances substance P-induced behaviors via metabolic inhibition: in vivo evidence for a new mechanism of neuromodulation.
Mao J; Coghill RC; Kellstein DE; Frenk H; Mayer DJ
Brain Res; 1992 Mar; 574(1-2):157-63. PubMed ID: 1379108
[TBL] [Abstract][Full Text] [Related]
20. The role of CGRP receptor antagonist (CGRP8-37) and Endomorphin-1 combination therapy on neuropathic pain alleviation and expression of Sigma-1 receptors and antioxidants in rats.
Janzadeh A; Karami Z; Hosseini M; Zarepour L; Yousefifard M; Nasirinezhad F
J Chem Neuroanat; 2020 Jul; 106():101771. PubMed ID: 32092447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
